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Background. In Russia, active case finding (ACF) for certain population groups has been practiced
uninterruptedly for many decades, but no studies comparing ACF and passive case finding (PCF) approaches
in Russia have been published.
Objective. The aim of this study was to describe the main differences in symptoms and diagnostic delay
between patients who come to TB services through PCF and ACF strategies.
Methods. A cross-sectional study was conducted among 453 new pulmonary tuberculosis (PTB) patients, who
met criteria of TB diagnostic delay in Arkhangelsk.
Results. ACF patients used self-treatment more often than PCF patients (90.1% vs. 24.6%) and 36.3% of them
were alcohol abusers (as opposed to only 26.2% of PCF patients). The median patient delay (PD) in PCF was
4 weeks, IQR (18 weeks), and less than 1 week in ACF. Twenty-three per cent of the PCF patients were seen
by a medical provider within the first week of their illness onset.
Conclusion. Patients diagnosed through ACF tended to under-report their TB symptoms and showed low
attention to their own health. However, ACF allowed for discovering TB patients earlier than PCF, and this
was also the case for alcohol abusing patients. PCF systems should be supplemented with ACF strategies.
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S
ince the 1990s there has been a substantial im-
provement in access to high-quality tuberculosis
(TB) services globally (1). However, too many
people still remain undiagnosed or diagnosed late. This
leads to a persistent high risk of transmission in some
societies. TB screening can reduce the delay in diagnosis
and thus the risk of poor disease outcomes and TB
transmission (2).
In 2013, the World Health Organization (WHO) issued
guidelines for active TB screening defined as ‘‘the
systematic identification of people with suspected active
TB, in a predetermined target group, using tests, exam-
inations or other procedures that can be applied rapidly’’
(2). The aim of screening is to efficiently distinguish
people with a high probability of having active TB from
those with low probability (2). Health providers initiate
systematic screening of people who, for some reason, do
not seek health care; people have no symptoms or cannot
recognize them; people who consider their health prob-
lem to not warrant medical attention; or those who face
barriers to accessing health care (2).
National TB control programs might have low impact
on true incidence because patients are diagnosed and
treated too late (3). Active case finding (ACF) could
be effective in providing early diagnosis and is typically
aimed at TB high-risk groups (homeless, prisoners, pa-
tients in nursing homes, and residents of impoverished
areas). Because ACF has to examine people at certain
intervals, some patients might become infectious between
the regular screenings and delay their health seeking
because they depend on the regular screenings. The ef-
fects of a successful ACF program would thus be optimal
if passive case finding (PCF) is strengthened (4). To be
successful, ACF should be provided with the expansion
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of TB diagnostic facilities in the community (5) and while
promoting favourable health seeking behaviours (6).
The DOTS strategy is based entirely on PCF and it
is due time to consider whether ACF could strengthen
it (7). Cost-efficiency of ACF depends on whether it
reduces secondary cases in the community (8), prevents
deaths, saves life years and increases quality-adjusted life
years (9). Additionally, older, female and HIV-infected
patients with TB are more difficult to reach by PCF (10).
Most patients are automatically delayed because the
definition of suspected TB requires a cough for more
than 2 weeks duration. Adding to that is the patient delay
(PD) in seeking care and the health systems delay (HSD)
in reaching the correct diagnosis and initiating adequate
TB treatment. Some pulmonary tuberculosis (PTB) cases
may be lost because a cough is common for smokers
and is considered a ‘‘normal’’ thing. For example, in Sri
Lanka a cough of more than 2 weeks duration had been
ignored in many of the TB cases (11,12). Moreover,
respiratory symptoms are often missed by doctors during
examination as well as the production of sputum (12). So,
patients may circulate as ‘‘non-tuberculosis’’ in the health
system for a long time. Commonly, all patients having
cough, fever and shortness of breath are treated as having
simple respiratory tract infection. Only when the patient
does not respond to treatment is PTB considered as a
‘‘second line’’ possibility. The low sensitivity and speci-
ficity of the symptoms, signs and the general examination
of TB cause health system delay (HSD) (13,14). Sputum
culture-negative individuals with chest X-ray abnormal-
ities are at a high risk of disease progression if they are
undiagnosed as TB (15). PTB should be suspected and
excluded at least by chest X-ray, which is readily available
technology (11).
Alcohol problems have been associated with TB
disease and diagnostic delay (DD) (1621) caused by
decreasing social activity. These individuals face employ-
ment difficulties, homelessness, social marginalization,
increased risk of infection, re-infection and co-infection
with HIV (1923). At population level we have described
an association between the incidence of alcohol psy-
choses and the TB incidence in the same year in northern
Russia suggesting a link between excessive levels of
alcohol consumption and TB incidence (24).
So, the population suffering from TB is not representa-
tive of the ‘‘usual’’ patients in outpatient clinics; they rarely
seek care, and when they seek help they are less likely
to be diagnosed. PCF strategy supposed that patients
are generally ‘‘active care seekers’’ who are examined for
TB cases because they have symptoms compatible with
TB. The weakest point of PCF is ‘‘waiting for patients’’
willingness to ask for help (25,26). Many individuals with
smear-negative bacteriologically positive pulmonary TB do
not report any symptoms at all (2729). In South Korea,
the prevalence rate of pulmonary TB among homeless
people was much higher than among the general popula-
tion (30). The PCF approach may leave a large pool of
undetected prevalent TB cases even in settings with well-
functioning TB programs (31).
In Russia, ACF for certain population groups has
been practiced uninterruptedly for many decades. But no
studies comparing ACF and PCF approaches in Russia
have been published. The aim of this study was to de-
scribe the main differences in symptoms and DD between
patients who come to TB services through PCF and ACF
strategies.
Methods
Setting
The Arkhangelsk region is located 1,200 km north of
Moscow. Its total area is 589,913 km2. The population,
as of 2012, was 1,213,533 people. The region consists of
20 districts and includes 15 cities and more than 4,000
villages (3234).
TB management in the Arkhangelsk region
Each district has a TB specialist. Arkhangelsk Regional
Anti-tuberculosis Dispensary (ARAD) is the main in-
stitution responsible for the care of TB patients. It has
both inpatient and outpatient departments and can pro-
vide treatment for all cases of TB, including multidrug-
resistant TB (MDR TB) and extensively drug-resistant
TB (XDR TB) cases.
All smear-positive cases are hospitalized at ARAD,
and smear-negative patients start the outpatient treat-
ment. All examinations are free of charge, but the travel
costs rest on the patient. All patients with TB, as well as
all TB deaths, in the Arkhangelsk region are registered
in ARAD. An extensive questionnaire including socio-
demographics, symptoms and delay is filled in for each
diagnosed patient. No private practitioners treat TB.
In spite of this, DOTS has been provided in the region
since 1998. The MDR TB management program dates
from 2005, and active screening for TB is conducted
according to Russian regulations (3537). The WHO case
definition is used here (38).
All children younger than 14 years are tested by
tuberculin skin test annually. Military, maternity staff,
household contacts with tubercular people and ex-TB
patients after cure or completion of treatment are tested
once every 2 years; HIV-infected people, mentally ill
people, and people released from prison are examined
every 2 years; and prisoners and people at pre-trial
centres are examined by X-ray twice a year. All staff
working in any children’s or social services (including
school and preschool teachers), as well as patients with
any chronic lung disease, any gastrointestinal disease, any
chronic urinary diseases, diabetes, as well as homeless
people and migrants must be examined once a year
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(including X-ray examination). People with any respira-
tory symptoms who enter the hospital for reasons other
than TB, individuals living with pregnant women and
newborns, military recruits, persons with first diagnosis
of HIV and people who work with hazardous and
harmful substances must undergo an initial examination.
Other populations older than 14 years should be ex-
amined once every 2 years (3537).
In 2012, 486,437 people were examined by X-ray
digital screening for diagnostic tuberculosis (ACF). This
constituted 49.4% of the entire adult population of the
region. In 2012, 12,428 patients suspected of having TB,
who had a cough lasting more than 2 weeks were asked
to submit to a sputum test by the microscopy method
(PCF) and 181 TB cases were diagnosed (1.46% positive
diagnostic). Among 431 new TB cases, 181 (41.9%) were
diagnosed by PCF; 198 (45.5%) by X-ray examination
(ACF) (34 (7.9%) because of contact with TB patients;
18 (4.2%) by autopsy); and 2 (0.5%) by the tuberculin
skin test in children. (Report of regional TB service).
Among new cases, 66 ACF patients (33.3%) and 110 PCF
patients (61%) had positive smear microscopy (Figure 3).
Before initiation of the treatment, every TB patient is
examined by the smear microscopy, GeneXpert, Bactec-
MGIT, Lowenstein Jensen media, and digital X-ray and
tomography X-ray examination. Smear and culture
positive patients are examined for drug susceptible test
mycobacteria by the LPA method.
In 2012, 239 (21.4/100,000) new and relapsed TB cases
were confirmed by smear microscopy, 362 (32.4/100,000)
cases by smear microscopy and GeneXpert, Bactec
MGIT, Lowenstein Jensen media and 611 (54.7/
100,000) by all these methods plus X-ray examination
only (Figures 1 and 2). TB patients with X-ray abnorm-
alities without bacteriological confirmation received 2
courses of antibiotic therapy before registration of their
TB cases.
Among 1,213,533 citizens in the civil sector excluding
the penitentiary system there were diagnosed 431 new TB
cases, 82 relapses, 7 treatment after loss to follow up and
5 treatment after failure patients. Among them were 155
new MDR TB patients (37.5%) and 7 patients with XDR
TB. Among the patients, 68.2% of new cases experienced
treatment success, 11.6% continued MDR-TB treatment,
46.2% of relapses experienced treatment success and
22.0% were continued MDR-TB treatment patients,
71.4% treatment loss to follow up patients and, 60.0%
of failure patients were cured and 1 patient continued
MDR-TB treatment. Total treatment success (cured and
treatment completed) among all TB patients registered in
2012 was 63.5% and continued MDR-TB treatment was
13.1% (Figure 3).
Definition of variables
There is no definite time for DD in literature and no
WHO guidelines for this. When comparing DD for
patients diagnosed with TB by ACF versus PCF we
decided to select the patients who had positive smear
microscopy because these patients are more infectious in
society. The contribution of ACF to reduce community
transmission might be substantial in a situation where
half of the population is subject to regular screening
(3537). We used the following classification of DD:
patient delay (PD) is the duration of time from onset of
symptoms to the first interaction with a medical health
provider, health system delay (HSD) is the time from the
first visit to the initiation of treatment and the total delay
(TD) is the time from onset of symptoms to initiation of
treatment (3941). PCF was defined as detecting active
TB disease among symptomatic patients who contact the
health care system for diagnosis of symptoms (42) and
ACF as a health care system special effort to increase the
detection of TB in a given population (43).
Sample and design
A cross-sectional study was conducted between 1 March
2012 and 5 February 2013 among new smear-positive
PTB patients in the Arkhangelsk region. We used
continuous sampling for data gathering and included all
patients who met criteria of TB DD (n453) during
20072011. We did not conduct face-to-face interviews;
all the data were taken from individual medical records.
The major pulmonary symptoms included were pre-
sence of cough, production of sputum, weakness, fever,
dyspnoea, loss of appetite, and sweating. Alcohol and
smoking anamnesis were also included. The group was
split into 2 groups: patients who came on their own to the
health system because of symptoms (PCF) and those who
came for the prescribed regular medical examination
(ACF). Differences in symptoms and delays in the
subgroups were estimated.
Statistical analysis
SPSS version 20.0 was used for analysis. Because the data
were skewed, intra-group differences were compared
using the non-parametric MannWhitney criterion for
Smear
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Lowenstein Jensen media
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Digital X-ray
54.7
Fig. 1. Number of new and relapsed TB cases (per 100,000)
confirmed by various methods in the Arkhangelsk region 2012.
Note: The cases in a bigger ellipsis include smaller ones (Report
of regional TB service).
TB case finding strategies in Arkhangelsk
Citation: Int J Circumpolar Health 2014, 73: 23515 - http://dx.doi.org/10.3402/ijch.v73.23515 3
(page number not for citation purpose)
118.7
98.2
88.2 90.6
82.6
88.4
72.9 70.6 67.9 64.7 64.2
54.7
38.7 33.9 32.8 33.9 31.2 32.4 27.8
25.6 27 26.6 26 21.4
54.3 49.9 43.7 45.3 43.3 43.7 38.7 37.2 37.9 38 41.5
32.4
15.2 16.1 17.8 18.5 19.8 15.5 12.5 10.3 8 8.4 6.5 6.4
0
20
40
60
80
100
120
140
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Incidence of TB in Arkhangelsk region (including penitentiary system)
Incidence of pulmonary smear-positive TB
Incidence of pulmonary smear or  culture positive TB
Fig. 2. TB Incidence including penitentiary system (new cases and relapses) and mortality in Arkhangelsk Region 20012012 (per
100,000 population).
2208.10
1869.00
538.50
464.00
165.60
46.20
33.7032.00
17.50
11.90
11.10
9.20
1.00
10.00
100.00
1000.00
10000.00
1
HIV patients
Homeless people
People released from prison and
convicted people
Household contacts with
tuberculosis people
Migrants
Jobless and pensioners
Patients with all chronic lung
disease
Ex-TB patients that shows
residual X-ray changes after
completion of treatment
Patients with gastrointestinal
diseases
Working people
Staff working in all children's
services
Patients with diabetes
Maternity staff
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2 independent samples, KruskalWallis tests for more
than 2 independent samples in ordinal and categorical
data. Medians, modes and interquartile scores were
calculated. Linear regression analyses were performed
to assess the relative impact of predictor variables on the
outcome variables, and a p-value of B0.05 was consid-
ered statistically significant. We used p-value of B0.017
for data evaluation in pairwise comparison with 3
variables using MannWhitney criterion.
We included time from initial symptoms till TB dia-
gnosis (PD) and time from first visit to the health system
till TB treatment initiation (HSD) and time from symp-
toms onset till treatment initiation (TD) as the dependent
variables and various patient characteristics as the inde-
pendent variables.
Results
Patient characteristics
The patients were new smear-positive PTB patients
(81.5% males and 18.5% females), aged 45.3 years (range
being 2086 years). Socio-economic characters of the
patients are presented in Table I. Most of the patients
lived in Arkhangelsk, were jobless and had secondary
school education. Sixty-six per cent of patients in the
PCF group and 63.3% of the patients in the ACF group
lived alone. Thirty per cent of the patients had been
imprisoned; 90% used alcohol, and half of them reported
dependency; more than 80% were smokers and the mean
time of smoking was 24.0 years (IQR 1630). Only 3%
had ever used psychoactive drugs. Eighty per cent of the
patients were unemployed and 11% of them had no
housing (Tables I and IV).
Symptoms and health-seeking period
During the first visit to health care, 65.3% of patients
reported the following symptoms: cough (90.0%), fever
(64.7%), weight loss (55.4%), sputum (40.2%), weakness
(33.6%), sweating (26.9%), dyspnoea (25.8%) and loss of
appetite (25.8%). However, only 62.3% of the patients
came to the health care system because of symptoms
(PCF). Others were called for a prescribed medical
examination and digital X-ray screening (ACF).
One fifth of the patients (21.0%) came to a hospital as
an emergency. All patients had visited a medical health
provider initially (68.7% of them came to a district health
centre). Most of them (88.5%) did not use self-treatment
before visiting the health centre.
Most of the patients (77.5%) had a HSD of less than 2
weeks (Tables II and III). The median PD was 4 weeks,
IQR (18 weeks). Based on the cumulative distribution
44.2% of the subjects consulted a medical health provider
within the first week of the onset of their illness. The
longest delay was reported to be 192 weeks.
Patients who used alcohol had a longer PD than those
who did not (p0.015); patients who used self-treatment
also had a longer time of PD (Table III). Patients who
had a high level of education had longer HSD than those
who only graduated from primary school (p0.006). In a
linear regression analysis the symptoms correlated with
time from the first visit to contact TB service (b6.081;
95% CI 3.83, 8.33; R20.059).
Active case finding versus passive case finding
There were 171 (37.8%) patients diagnosed by ACF and
282 by PCF. Patients who came by ACF had less time
from the symptoms onset until TB diagnosis (1.0 weeks
Table I. Socio-economic characteristics of patients with TB DD
Characteristics Number
Family status
Single 210
Divorced 30
Widow(er) 60
Civil marriage 61
Married 91
Education
High 119
Middle 254
Basic 80
Living conditions
Good 186
Poor 217
No accommodation 50
Work
Permanent 74
Periodic 56
Retired 27
Disabled 28
Unemployed 258
Alcohol
No 47
User 270
Abuser 136
Reason for visit to health system
Annual examination 157
Symptoms 282
Contact 14
First medical institution
Ambulance 95
Doctor assistant 22
District hospital 311
Anti-TB dispensary 25
Self-treatment
No 401
Yes 52
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vs. 6.9 weeks, pB0.000) and less time TD (1.0 vs. 1.5,
pB0.000) than those who had come by PCF. Forty-two
patients in the ACF group had symptoms before first
contact with the health system and showed mean PD
2.36 weeks (Mo0; IQR 04) and mean TD3.1
(Mo0, IQR 03). Those who had inadequate or no
housing and had employment showed longer HSD time
Patients in ACF group used self-treatment more often
than PCF patients (90.1% vs. 24.6%; p0.002). Addi-
tionally, 36.3% of ACF patients were alcohol abusers
while only 26.2% of PCF patients abused alcohol
(p0.016). Among PCF patients the median PD was 4
weeks, IQR (18 weeks), while the median time for ACF
was less than 1 week.
Twenty-three per cent of the PCF patients were seen by
a medical provider within the first week of their illness
onset (Table III). In linear regression analysis, symptoms
correlated with time from first visit to contact TB service
(b6.143; 95% CI 0.52, 11.77; R20.016) (Table IV).
Discussion
We described the symptoms of patients who contacted
the TB services through ACF and PCF strategies. We
gathered all data about all patients in the Arkhangelsk
region with DD for 5 years, so we described a common
pattern of reporting patients’ complains. There is no
missing data, but the quality of anamnesis in the medical
documentation is doubtful.
Table II. Parameters of DDs (weeks)
PD HSD
Variables Mean Median (Q1Q3) p Mean Median (Q1Q3) p
Sex
Male 5.07 2 (06) 0.07 1.34 0 (00) 0.756
Female 3.05 0.5 (04) 1.06 0 (00)
Family
Single 4.47 1.0 (05) 0.71 1.42 0 (00) 0.11
Married 5.14 1 (06) 1.05 0 (01)
Education
High 4.71 3 (06) 0.139 1.84 0 (02) 0.07
Middle 4.59 1 (04) 0.91 0 (00)
Basic 5.00 1 (04) 1.69 0 (00)
Prison
No 4.45 2 (06) 0.23 1.11 0 (00) 0.55
Yes 5.25 1 (04) 1.71 0 (01)
Housing
None/poor 4.06 1 (04) 0.13 1.09 0 (00) 0.24
Yes 5.61 2 (06) 1.58 0 (00)
Job
Work 3.44 1 (06) 0.72 1.13 0 (00) 0.29
Jobless 5.05 1 (06) 1.34 0 (00)
Alcohol
No 3.28 2 (05) 0.016 2.13 0 (02) 0.017
Use 5.46 2 (06.25) 1.41 0 (00)
Abuse 3.66 0 (04) 0.76 0 (00)
Reason for seeking medical help
ACF 1.01 0 (00) 0.000 1.02 0 (00) 0.19
PCF 6.93 4 (18) 1.45 0 (00)
Self-treatment
No 4.44 1 (04) 0.000 1.31 0 (00) 0.007
Yes 6.67 4 (38) 1.13 0 (01)
First medical institution
Ambulance 4.14 1 (14) 0.024 0.95 0 (00) 0.629
Doctor assistant 3.91 2 (06) 1.05 0 (02.25)
District health centre 5.18 2 (06) 1.51 0 (00)
Anti-TB dispensary 1.44 0 (02) 0.12 0 (00)
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In 2012, 12,428 patients suspected of having TB were
asked to submit to a sputum test (PCF), which revealed
181 TB cases (14.9/100,000). Among 431 new TB cases,
41.9% were diagnosed by PCF and 58.1% by ACF
(Report of regional TB service). The TB DD is an
indicator of work efficiency at outpatient clinics, and
family doctors have financial responsibility for timely
diagnosis, so, these data are valid. Each case of TB
death or a severe case of TB is discussed at the medical
conference. Administrators of outpatient clinics con-
trol the quality of diagnosis of socially important dis-
eases (oncological diseases, TB, HIV and others). Clinic
administrators can reduce a doctor’s monthly salary if
the findings of the medical conference confirm poor
performance.
ACF allowed identifying TB patients within the first
week, while patients who arrived at the health care ser-
vice by PCF had 6.9 weeks from symptoms onset until
contact with the health system. Patients in the ACF
group rarely had TB symptoms and used self-treatment
more often than PCF patients. A possible explanation is
that self-treatment decreased the intensity of the TB
symptoms, which reduced the desire of people to contact
the health system.
Additionally, 36.3% of ACF patients were alcohol
abusers versus 26.2% of PCF patients; perhaps alcohol
mitigates TB symptoms and pushes people away from
social institutions including the health care system. ACF
decreases time delay: PCF patients had a median PD of
4 weeks (IQR 18 weeks), only 23% of them were seen
during first week from symptoms onset, while most ACF
patients were seen within 1 week.
Table III. Parameters of DDs for patients who had symptoms (weeks)
PCF
PD HSD ACF with symptoms
Variables Mean
Median
(Q1Q3) p Mean
Median
(Q1Q3) p Mean
Median
(Q1Q3) p Mean
Median
(Q1Q3) P
Sex
Male 7.32 4 (18) 1.94 1.39 0 (00) 0.39 2.03 0 (04)  1.56 0 (01.25) 0.25
Female 4.91 2 (0.758) 1.78 0 (01.25) 3.75 2.5 (1.255.5) 0.63 0 (01.75)
Family
Single 6.58 4 (18) 0.78 1.68 0 (00) 0.11 2.47 2 (04) 0.72 1.06 0 (00) 0.36
Married 7.64 3 (18) 0.98 0 (01) 2.0 0.5 (04.5) 2.4 1.5 (04)
Education
High or Middle 6.80 4 (18) 0.3 1.22 0 (01) 0.65 2.36 1 (04) 0.84 1.49 0 (02) 0.18
Basic 7.52 3 (07.25) 2.56 0 (00) 2.33 1 (01) 0 0 (00)
Housing
Good 8.39 4 (18) 0.04 1.39 0 (01) 0.45 2 0 (03)  0.4 0 (00.5) 0.03
None/poor 5.86 3 (08) 1.5 0 (00) 2.6 2 (04) 0.48 0 (01)
Job
Yes 5.27 4 (17) 0.83 0.97 0 (00) 0.90 2.38 1.5 (0.253.75) 0.6 2.38 1 (03.5) 0.043
Jobless 7.36 4 (18) 1.58 0 (01) 2.35 0.5 (04) 1.15 0 (00.25)
Alcohol
No 4.90 4 (27) 0.70 2.29 0 (02) 0.25 0.4 0 (01) 0.6 2.38 0 (05.5) 0.53
Use 7.18 4 (18) 1.35 0 (00) 2.62 2 (04) 1.27 0 (01.5)
Self-treatment
No 6.79 3 (08) 0.001 1.48 0 (00) 0.44 2.26 0 (04) 0.18 1.51 0 (01) 0.44
Yes 7.71 6 (310) 1.33 0 (01.25) 2.86 3 (14) 0 0 (02)
Table IV. Time of patients’ and health system delay in some
countries
Country PD HSD Reference
Vietnam 3 weeks 1 week (44)
China 10 days 2 days (45)
Ethiopia 30 days 21 days (46)
Nepal 50 days 18 days (47)
France 47 days 48 days (48)
Spain  6 days (41)
Uganda 1 week 9 weeks (49)
Norway 28 days 33 days (50)
Rwanda 25 days 28 days (51)
Ethiopia 60 days 6 days (52)
South Africa 30 days 14 days (53)
Russia 16,7 days 50 days (54)
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One third (34.7%) of patients had no symptoms during
the first visit to the health care system. They contacted
doctors because of such ‘‘obligatory’’ demands as a re-
quired annual medical examination, or X-ray examina-
tion or because of contact with a TB patient (Table I).
Moreover, 24.6% of ACF patients reported symptoms
but did not ask for medical help before screening. It
seems that patients denied TB symptoms in daily life,
which agreed with other studies that found only a deadly
threat is a motivator for contacting a health system (55).
One fifth of the patients (21.0%) came to a hospital as an
emergency admission. The fact that 40% had sputum
from 2 till 62 weeks before the visit to a doctor showed
that they was perceived sputum production as a ‘‘nothing
unusual’’ situation. According to other research, doctors
often miss respiratory symptoms because they are
‘‘normal’’ for some patients (12). Russian researchers
described that often many data from anamnesis, clinical
data and examination results were not used by doctors
for diagnostic decision making (54). This was not sup-
ported by our findings, because most of the patients had
HSD less than 2 weeks. We can say that PD was more
important in our setting (Tables II and III). Our findings
showed that about half of the patients (45.8%) visited the
health system 2 weeks from symptom onset and would
not be picked up by the PCF strategy.
Some authors described stigma as an important barrier
to TB and other infectious disease diagnosis (56,57). This
was not supported by our previous study (unpublished
data). Socially less vulnerable people who used self-
treatment showed a longer time of PD (Table III). This
contradicts numerous studies that reported an associa-
tion between patient delay and low education and inad-
equate housing (40,44,52,53). Patients who had attained
a higher educational level also had a longer time of PD
(Tables III and IV). A possible explanation is that sick
persons without housing cannot live in a harsh climate
and reported to the health system earlier. These persons
were alcohol abusers and had a shorter PD than alcohol
users (Table II). Patients with more education often have
comfortable housing, so they may have a longer time of
PD. Moreover, they use self-treatment, which increases
PD (40,44,52,53). Additionally, there were no differences
among ACF patients because ACF strategies do not
consider these factors. HSDs were less than 2 weeks for
the majority of the patients (77.5%). It seems that the
main reason for DD is a low level of patient attention
to their own conditions. If a patient reaches a health
service and shows symptoms, he/she will be diagnosed in
a short time.
Gender can increase or decrease DD time depending
on country customs related to stigma (40,44,52,53). We
found longer male PD in passive case finding (Table IV),
which was supported by qualitative data stating that men
were more likely to have patient delays than women, who
were more likely to have health system delay (unpub-
lished data).
Conclusion
Patients diagnosed through ACF tended to under-report
their TB symptoms and showed low attention to their
own health. However, ACF allowed TB patients to be
revealed earlier than PCF and this was also the case for
alcohol abusing patients. In risk groups, ACF is more
effective than PCF. PCF systems should be supplemented
with ACF strategies for risk groups (homeless, prisoners,
household contact with TB patients, HIV patients).
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